Tnf-Alpha (Rs1800629), Cdkal1 (Rs7754840, Rs7756992), Mtnr1b (Rs10830963, Rs1387153) Polymorphisms Were Linked To Gestational Diabetes Mellitus (Gdm) Risks: Based On An Updated Meta-Analysis

Fang Gao,Jinxiu Xu,Guangya Wang,Dongxia Fu,Ningning Guo
2016-01-01
Abstract:The rs1800629 of TNF-alpha (Tumor Necrosis Factor-alpha), rs7754840, rs7756992 of CDKAL1 (CDK5 regulatory subunit associated protein 1-like 1), rs10830963, rs1387153 of MTNR1B (Melatonin Receptor 1B) have been reported previously. Our study aims at investigating the potential role of the above SNPs (Single Nucleotide polymorphisms) in the risks of GDM (Gestational Diabetes Mellitus). An updated meta-analysis was thus conducted via Stata/SE 12.0 software. The six online databases (PubMed, EMBASE, WOS, EBSCO, WANFANG and CNKI) were searched to obtain the relevant literature. 8 articles for TNF-alpha gene, 6 articles for CDKAL1 gene and 10 articles for MTNR1B gene were finally included. The p value, OR (odd radio) and 95% CI (confidence interval) from Mantel-Haenszel statistics were then calculated. Compared with the control group, a significantly increased GDM risk was observed for TNF-alpha rs1800629, CDKAL1 rs7754840, rs7756992, MTNR1B rs10830963 and rs1387153, in the overall or Asian population under almost genetic comparisons (OR>1, p<0.05). The potential publication bias was excluded by Begg's test and Egger's test. Sensitivity meta-analyses further indicated the stable results. In summary, it is more likely that TNF-alpha (rs1800629), CDKAL1 (rs7754840, rs7756992), MTNR1B (rs10830963, rs1387153) polymorphisms are associated with an increased GDM risk.
What problem does this paper attempt to address?